Key result
Delayed initiation of cardiac rehabilitation is linked to ~15% lower uptake and reduced life expectancy.
Why the study?
Despite national guidelines on timeliness, many health services fail to offer cardiac rehabilitation in a timely manner, and the impact on patient health and healthcare provider burden remains unquantified.
Does delayed delivery of cardiac rehabilitation reduce uptake, completion, and life expectancy in patients with cardiovascular disease?
Observational
Yes
Does delayed delivery of cardiac rehabilitation reduce uptake, completion, and life expectancy in patients with cardiovascular disease?
Effect estimate: 15.3% reduction in uptake, 7.4% reduction in completion
Delayed initiation of cardiac rehabilitation significantly reduces patient uptake and completion, leading to a quantifiable and avoidable loss in life expectancy.
Delays in cardiac rehabilitation may reduce uptake and life expectancy; hypothesis-generating and should not yet change practice.
BACKGROUND: Despite its role as an effective intervention to improve the long-term health of patients with cardiovascular disease and existence of national guidelines on timeliness, many health services still fail to offer cardiac rehabilitation in a timely manner after referral. The impact of this failure on patient health and the additional burden on healthcare providers in an English setting is quantified in this article. METHODS: Two logistic regressions are conducted, using the British Heart Foundation National Audit of Cardiac Rehabilitation dataset, to estimate the impact of delayed cardiac rehabilitation initiation on the level of uptake and completion. The results of these regressions are applied to a decision model to estimate the long-term implications of these factors on patient health and National Health Service expenditure. RESULTS: We demonstrate that the failure of 43.6% of patients in England to start cardiac rehabilitation within the recommended timeframe results in a 15.3% reduction in uptake, and 7.4% in completion. These combine to cause an average lifetime loss of 0.08 years of life expectancy per person. Scaled up to an annual cohort this implies 10,753 patients not taking up cardiac rehabilitation due to the delay, equating to a loss of 3936 years of life expectancy. We estimate that an additional £12.3 million of National Health Service funding could be invested to alleviate the current delay. CONCLUSIONS: The current delay in many patients starting cardiac rehabilitation is causing quantifiable and avoidable harm to their long-term health; policy and research must now look at both supply and demand solutions in tackling this issue.
No takes yet. Share an insight, caveat, or question.
Hinde et al. (2020) conducted an observational in Cardiovascular disease. Delayed cardiac rehabilitation initiation vs. Timely initiation within recommended timeframe was evaluated on Uptake and completion of cardiac rehabilitation, and life expectancy (15.3% reduction in uptake, 7.4% reduction in completion). Delayed initiation of cardiac rehabilitation reduced uptake by 15.3% and completion by 7.4%, leading to an average lifetime loss of 0.08 years of life expectancy per person.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: